FLC
MRTX

Fifth Lane Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Fifth Lane Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$1.18M – 176
2023
Q4 		$1.18M Buy
+20,000
New +$1.18M 1.38% 9